133 related articles for article (PubMed ID: 11092538)
1. Development and assessment of a 3D pharmacophore for ligand recognition of BDZR/GABAA receptors initiating the anxiolytic response.
Harris DL; Loew G
Bioorg Med Chem; 2000 Nov; 8(11):2527-38. PubMed ID: 11092538
[TBL] [Abstract][Full Text] [Related]
2. Benzodiazepine-induced hyperphagia: development and assessment of a 3D pharmacophore by computational methods.
Filizola M; Harris DL; Loew GH
J Biomol Struct Dyn; 2000 Apr; 17(5):769-78. PubMed ID: 10798522
[TBL] [Abstract][Full Text] [Related]
3. Determinants of recognition of ligands binding to benzodiazepine receptor/GABA(A) receptors initiating sedation.
Harris DL; DeLorey TM; He X; Cook JM; Loew GH
Eur J Pharmacol; 2000 Aug; 401(3):271-87. PubMed ID: 10936485
[TBL] [Abstract][Full Text] [Related]
4. Development of a 3D pharmacophore for nonspecific ligand recognition of alpha1, alpha2, alpha3, alpha5, and alpha6 containing GABA(A)/benzodiazepine receptors.
Filizola M; Harris DL; Loew GH
Bioorg Med Chem; 2000 Jul; 8(7):1799-807. PubMed ID: 10976528
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site.
Schove LT; Perez JJ; Loew GH
Bioorg Med Chem; 1994 Oct; 2(10):1029-49. PubMed ID: 7773620
[TBL] [Abstract][Full Text] [Related]
6. Discovery of anxiolytic 2-ferrocenyl-1,3-thiazolidin-4-ones exerting GABAA receptor interaction via the benzodiazepine-binding site.
Pejović A; Denić MS; Stevanović D; Damljanović I; Vukićević M; Kostova K; Tavlinova-Kirilova M; Randjelović P; Stojanović NM; Bogdanović GA; Blagojević P; D'hooghe M; Radulović NS; Vukićević RD
Eur J Med Chem; 2014 Aug; 83():57-73. PubMed ID: 24950490
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling and QSAR analysis of the interaction of flavone derivatives with the benzodiazepine binding site of the GABA(A) receptor complex.
Marder M; Estiú G; Blanch LB; Viola H; Wasowski C; Medina JH; Paladini AC
Bioorg Med Chem; 2001 Feb; 9(2):323-35. PubMed ID: 11249125
[TBL] [Abstract][Full Text] [Related]
8. A behaviorally selective class of thiophene-containing benzodiazepine receptor ligands.
Schove LT; Chen SW; Beatty M; Maguire PA; Davies MF; Loew GH
Bioorg Med Chem; 1995 Nov; 3(11):1547-61. PubMed ID: 8634835
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors.
Cox ED; Diaz-Arauzo H; Huang Q; Reddy MS; Ma C; Harris B; McKernan R; Skolnick P; Cook JM
J Med Chem; 1998 Jul; 41(14):2537-52. PubMed ID: 9651158
[TBL] [Abstract][Full Text] [Related]
10. Ligands for the benzodiazepine binding site--a survey.
Teuber L; Wätjens F; Jensen LH
Curr Pharm Des; 1999 May; 5(5):317-43. PubMed ID: 10213798
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Biological Evaluation of Imidazo[1,5-a]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors.
Cappelli A; Anzini M; Castriconi F; Grisci G; Paolino M; Braile C; Valenti S; Giuliani G; Vomero S; Di Capua A; Betti L; Giannaccini G; Lucacchini A; Ghelardini C; Di Cesare Mannelli L; Frosini M; Ricci L; Giorgi G; Mascia MP; Biggio G
J Med Chem; 2016 Apr; 59(7):3353-72. PubMed ID: 26982523
[TBL] [Abstract][Full Text] [Related]
12. In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates.
Brouillet E; Chavoix C; Bottlaender M; Khalili-Varasteh M; Hantraye P; Fournier D; Dodd RH; Mazière M
Brain Res; 1991 Aug; 557(1-2):167-76. PubMed ID: 1660750
[TBL] [Abstract][Full Text] [Related]
13. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
[TBL] [Abstract][Full Text] [Related]
14. Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents.
Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
Curr Top Med Chem; 2012; 12(4):286-311. PubMed ID: 22204484
[TBL] [Abstract][Full Text] [Related]
15. Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit.
Harris D; Clayton T; Cook J; Sahbaie P; Halliwell RF; Furtmüller R; Huck S; Sieghart W; DeLorey TM
J Med Chem; 2008 Jul; 51(13):3788-803. PubMed ID: 18537233
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.
Gudasheva TA; Deeva OA; Mokrov GV; Dyabina AS; Yarkova MA; Seredenin SB
Med Chem; 2019; 15(4):383-399. PubMed ID: 30457052
[TBL] [Abstract][Full Text] [Related]
17. The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptor.
Kahnberg P; Howard MH; Liljefors T; Nielsen M; Nielsen EØ; Sterner O; Pettersson I
J Mol Graph Model; 2004 Dec; 23(3):253-61. PubMed ID: 15530821
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Characterization of a Novel γ-Aminobutyric Acid Type A (GABA
Poe MM; Methuku KR; Li G; Verma AR; Teske KA; Stafford DC; Arnold LA; Cramer JW; Jones TM; Cerne R; Krambis MJ; Witkin JM; Jambrina E; Rehman S; Ernst M; Cook JM; Schkeryantz JM
J Med Chem; 2016 Dec; 59(23):10800-10806. PubMed ID: 27933953
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore, 3D-QSAR, and Bayesian model analysis for ligands binding at the benzodiazepine site of GABAA receptors: the key roles of amino group and hydrophobic sites.
Yang Y; Zhang W; Cheng J; Tang Y; Peng Y; Li Z
Chem Biol Drug Des; 2013 May; 81(5):583-90. PubMed ID: 23279907
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of 7-substituted 4-phenyl-6H-imidazo[1,5-a]thieno[3,2-f] [1,4]diazepines as safe anxiolytic agents.
Di Capua A; Reale A; Paolino M; Chemi G; Brogi S; Cappelli A; Giorgi G; Grande F; Di Cesare Mannelli L; Ghelardini C; Matucci R; Garofalo A; Anzini M
Eur J Med Chem; 2020 Aug; 200():112405. PubMed ID: 32492595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
